Conferences
- Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy
Sharma A, Ren X, Rosato A, Sangiolo D, Wang Z, Tettamanti S, Zhang Y, Rettinger E, Fenix KA, Sommaggio R, Cappuzzello E, Schmidt-Wolf IGH. Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy. Cancer Immunol Immunother. 2024 Jan 27;73(2):21. doi: 10.1007/s00262-023-03605-1. PMID: 38279995; PMCID: PMC10821962.
-
Advancing CIK cell immunotherapy: highlights from the second international conference on DC-CIK and CAR-CIK approaches.
Sharma A, Sangiolo D, Rosato A, Pu J, Hou J, Tettamanti S, Serafini M, Fenix KA, Introna M, Rambaldi A, Ren X, Schmidt-Wolf IGH. Advancing CIK cell immunotherapy: highlights from the second international conference on DC-CIK and CAR-CIK approaches. Cancer Immunol Immunother. 2025 Nov 3;74(12):361. doi: 10.1007/s00262-025-04216-8.
-
30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective.
Sharma A, Schmidt-Wolf IGH. 30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective. J Exp Clin Cancer Res. 2021 Dec 9;40(1):388. doi: 10.1186/s13046-021-02184-2.